Nephrology (Carlton, Vic.) · 2026
Nomogram-Based Admission Model to Predict Early Hypovolaemic Shock in Paediatric Nephrotic Syndrome: Derivation and Internal Validation.
СтатьяНаблюдательное исследованиеВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quang Ngo C, Hung Tran D, Ngoc Nguyen T B, My Le H, Trung Huynh T, Loan Duong T K, Mai Truong M A, Duc Tran H M
Аннотация
AIM: Hypovolaemic shock (HS) is an uncommon but life-threatening complication in paediatric nephrotic syndrome (NS), yet current guidelines lack a quantitative admission-time instrument to flag high-risk children. We aimed to develop and internally validate a simple model for early HS using routinely available clinical-laboratory data.
METHODS: We performed a single-centre observational study including 258 children with NS admitted to a tertiary paediatric hospital. HS within 24-h of admission was the outcome. Candidate predictors were routine admission variables. Multivariable logistic regression was used to derive a parsimonious model, which was presented as a nomogram. Internal validation and clinical utility were assessed using cross-validation and decision-curve analysis (DCA).
RESULTS: HS occurred in 37/258 (14.3%). The final 4-variable model retained age, haematocrit, serum albumin and serum sodium. Two markers remained strongly and independently associated with HS: serum albumin, OR = 2.17 per 1 g/L decrease (95% CI 1.68-3.07; p < 0.001); and serum sodium, OR = 5.79 per 5 mmol/L decrease (95% CI 1.86-22.75; p = 0.006). Age (OR 0.90 per year) and haematocrit (OR 1.47 per +5%) modestly improved discrimination. Apparent discrimination was excellent (AUC = 0.966; 95% CI 0.945-0.988; Brier 0.049) and remained high on cross-validation (AUC = 0.959; 95% CI 0.934-0.983; Brier 0.055). DCA showed a higher net benefit of the model than 'treat all' or 'treat none' between 20% and 50% risk.
CONCLUSION: A four-variable admission nomogram can stratify early HS risk in children with NS using routine data. External multicentre validation remains necessary.
METHODS: We performed a single-centre observational study including 258 children with NS admitted to a tertiary paediatric hospital. HS within 24-h of admission was the outcome. Candidate predictors were routine admission variables. Multivariable logistic regression was used to derive a parsimonious model, which was presented as a nomogram. Internal validation and clinical utility were assessed using cross-validation and decision-curve analysis (DCA).
RESULTS: HS occurred in 37/258 (14.3%). The final 4-variable model retained age, haematocrit, serum albumin and serum sodium. Two markers remained strongly and independently associated with HS: serum albumin, OR = 2.17 per 1 g/L decrease (95% CI 1.68-3.07; p < 0.001); and serum sodium, OR = 5.79 per 5 mmol/L decrease (95% CI 1.86-22.75; p = 0.006). Age (OR 0.90 per year) and haematocrit (OR 1.47 per +5%) modestly improved discrimination. Apparent discrimination was excellent (AUC = 0.966; 95% CI 0.945-0.988; Brier 0.049) and remained high on cross-validation (AUC = 0.959; 95% CI 0.934-0.983; Brier 0.055). DCA showed a higher net benefit of the model than 'treat all' or 'treat none' between 20% and 50% risk.
CONCLUSION: A four-variable admission nomogram can stratify early HS risk in children with NS using routine data. External multicentre validation remains necessary.
Предметные рубрики MeSH
HumansNephrotic SyndromeNomogramsFemaleMaleRisk FactorsPredictive Value of TestsChild, PreschoolDecision Support TechniquesReproducibility of ResultsChildShockBiomarkersLogistic ModelsInfantPatient AdmissionHematocritSerum AlbuminRisk AssessmentTime FactorsMultivariate AnalysisSodiumOdds RatioROC CurveArea Under CurveAge FactorsAdolescentHospitals, PediatricTertiary Care CentersChi-Square DistributionSerum Albumin, Human